← Leaderboards
Thomas Levin Geiser Andersen
University Of Michigan At Ann Arbor
$1,817,081
Attributed
$4,566,297
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,566,297 · 3
By mechanism
R01$2,979,383 · 2
U01$1,586,914 · 1
Top collaborators
- Julia F Charles5 shared
- Matthew T Drake4 shared
- Megan M Weivoda4 shared
- Ryan Dee Ross3 shared
- Joseph Michael Wallace3 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Laurie K. McCauley$14,844,916
- Nabanita S Datta$378,231
- Guozhi Xiao$3,555,168
- Hernan Roca$222,792
Others in their field
Other Emerging Leaders on “Bone”
- Bronwen Shaw · Medical College Of Wisconsin$24,584,971
- Scott Fry$21,470,000
- Olwen Hahn · Brigham And Women'S Hospital$13,421,925
- Geoffrey Roger Hill · Fred Hutchinson Cancer Center$11,372,371
- Tony Yuen · Icahn School Of Medicine At Mount Sinai$9,978,455
- Brian Hess · Revbio, Inc.$9,895,355
Research focus
BoneAutomobile DrivingCellsMouse ModelIn VitroCharacteristicsMediatingPhenotypeMutationIn VivoGenesTreatment StrategySkeletalAffectOsteoclastsOsteogenesisOsteoblastsOsteoporosisBone RemodelingInnovationResponseAlbers-Schonberg DiseaseBackBone Diseases
Grant awards (12)
How bisphosphonates affect bone matrix and remodeling: implications for atypical femoral fractures$353,132
R01 · FY2025 · AR
Mechanisms of bone fragility in Autosomal Dominant Osteopetrosis type II: from human to mouse and back$283,386
R01 · FY2025 · AR
Mechanisms of bone fragility in Autosomal Dominant Osteopetrosis type II: from human to mouse and back$127,550
R01 · FY2025 · AR
Mechanisms of bone fragility in Autosomal Dominant Osteopetrosis type II: from human to mouse and back$412,092
R01 · FY2024 · AR
Role of senescence in multiple myeloma tumorigenesis$394,000
U01 · FY2024 · AG
How bisphosphonates affect bone matrix and remodeling: implications for atypical femoral fractures$391,487
R01 · FY2024 · AR
How bisphosphonates affect bone matrix and remodeling: implications for atypical femoral fractures$464,873
R01 · FY2023 · AR
Mechanisms of bone fragility in Autosomal Dominant Osteopetrosis type II: from human to mouse and back$452,041
R01 · FY2023 · AR
Role of senescence in multiple myeloma tumorigenesis$398,706
U01 · FY2023 · AG
Mechanisms of bone fragility in Autosomal Dominant Osteopetrosis type II: from human to mouse and back$494,822
R01 · FY2022 · AR
Role of senescence in multiple myeloma tumorigenesis$402,991
U01 · FY2022 · AG
Role of senescence in multiple myeloma tumorigenesis$391,217
U01 · FY2021 · AG